Colistin resistance mechanisms in Klebsiella pneumoniae strains from Taiwan

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 5, 2015, Pages 2909-2913

  Cheng, Yi Hsiang ^a   Lin, Tzu Lung ^a   Pan, Yi Jiun ^a   Wang, Yu Ping ^b   Lin, Yi Tsung ^b   Wang, Jin Town ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COLISTIN; MESSENGER RNA;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERON; PRIORITY JOURNAL; PROTEIN CONFORMATION; TAIWAN; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MOLECULAR GENETICS;

COLISTIN; DRUG RESISTANCE, BACTERIAL; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; TAIWAN;

EID: 84931265768     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.04763-14     Document Type: Article

References (41)

1. Podschun R, Ullmann U. 1998. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589-603.
2. Lederman ER, Crum NF. 2005. Pyogenic liver abscess with a focus on Klebsiella pneumoniae as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol 100:322-331. http://dx.doi.org/10.1111/j.1572-0241.2005.40310.x.
3. Rapp RP, Urban C. 2012. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy 32:399-407. http://dx.doi.org/10.1002/j.1875-9114.2012.01035.x.
4. Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. 2012. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25:682-707. http://dx.doi.org/10.1128/CMR.05035-11.
5. Webster DP, Gaulton T, Woodford N, Pike R, Turton J, Perry C, Bowler IC. 2010. Emergence of carbapenem resistance due to porin loss in an extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy. Int J Antimicrob Agents 36:575-576. http://dx.doi.org/10.1016/j.ijantimicag.2010.08.003.
6. Yang D, Guo Y, Zhang Z. 2009. Combined porin loss and extended spectrum beta-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains. Curr Microbiol 58:366-370. http://dx.doi.org/10.1007/s00284-009-9364-4.
7. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, Cornaglia G, Garau J, Gniadkowski M, Hayden MK, Kumarasamy K, Livermore DM, Maya JJ, Nordmann P, Patel JB, Paterson DL, Pitout J, Villegas MV, Wang H, Woodford N, Quinn JP. 2013. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785-796. http://dx.doi.org/10.1016/S1473-3099(13)70190-7.
8. Chiu SK, Wu TL, Chuang YC, Lin JC, Fung CP, Lu PL, Wang JT, Wang LS, Siu LK, Yeh KM. 2013. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One 8:e69428. http://dx.doi.org/10.1371/journal.pone.0069428.
9. Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S, Network Eu S-I, Grundmann H, Pantosti A, Rossolini GM. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 19:(42):pii=20939. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20939.
10. Hancock RE. 1997. Peptide antibiotics. Lancet 349:418-422. http://dx.doi.org/10.1016/S0140-6736(97)80051-7.
11. Tran AX, Lester ME, Stead CM, Raetz CR, Maskell DJ, McGrath SC, Cotter RJ, Trent MS. 2005. Resistance to the antimicrobial peptide polymyxin requires myristoylation of Escherichia coli and Salmonella typhimurium lipid A. J Biol Chem 280:28186-28194. http://dx.doi.org/10.1074/jbc.M505020200.
12. Breazeale SD, Ribeiro AA, McClerren AL, Raetz CR. 2005. A formyltransferase required for polymyxin resistance in Escherichia coli and the modification of lipid A with 4-amino-4-deoxy-L-arabinose. Identification and function of UDP-4-deoxy-4-formamido-L-arabinose. J Biol Chem 280:14154-14167. http://dx.doi.org/10.1074/jbc.M414265200.
13. Gunn JS, Ryan SS, Van Velkinburgh JC, Ernst RK, Miller SI. 2000. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect Immun 68:6139-6146. http://dx.doi.org/10.1128/IAI.68.11.6139-6146.2000.
14. Chen YY, Ko TP, Lin CH, Chen WH, Wang AH. 2011. Conformational change upon product binding to Klebsiella pneumoniae UDP-glucose dehydrogenase: a possible inhibition mechanism for the key enzyme in polymyxin resistance. J Struct Biol 175:300-310. http://dx.doi.org/10.1016/j.jsb.2011.04.010.
15. Yan A, Guan Z, Raetz CR. 2007. An undecaprenyl phosphate-aminoarabinose flippase required for polymyxin resistance in Escherichia coli. J Biol Chem 282:36077-36089. http://dx.doi.org/10.1074/jbc.M706172200.
16. 2+-induced gene regulation in Pseudomonas aeruginosa. J Bacteriol 188:3995-4006. http://dx.doi.org/10.1128/JB.00053-06.
17. Miller AK, Brannon MK, Stevens L, Johansen HK, Selgrade SE, Miller SI, Hoiby N, Moskowitz SM. 2011. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Antimicrob Agents Chemother 55:5761-5769. http://dx.doi.org/10.1128/AAC.05391-11.
18. Cannatelli A, Giani T, D'Andrea MM, Di Pilato V, Arena F, Conte V, Tryfinopoulou K, the CSG, Vatopoulos A, Rossolini GM. 2014. MgrB inactivation is a common mechanism of colistin resistance in KPC carbapenemase-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother 58:5696-5703. http://dx.doi.org/10.1128/AAC.03110-14.
19. Cannatelli A, D'Andrea MM, Giani T, Di Pilato V, Arena F, Ambretti S, Gaibani P, Rossolini GM. 2013. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother 57:5521-5526. http://dx.doi.org/10.1128/AAC.01480-13.
20. Gaibani P, Lombardo D, Lewis RE, Mercuri M, Bonora S, Landini MP, Ambretti S. 2014. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates. J Antimicrob Chemother 69:1856-1865. http://dx.doi.org/10.1093/jac/dku065.
21. Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, Chaisiri K, Komalamisra C, Adelowo OO, Fagade OE, Banjo OA, Oke AJ, Adler A, Assous MV, Morand S, Raoult D, Rolain JM. 2014. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents 44:500-507. http://dx.doi.org/10.1016/j.ijantimicag.2014.07.020.
22. Kieffer N, Poirel L, Nordmann P, Madec J-Y, Haenni M. 2015. Emergence of colistin resistance in Klebsiella pneumoniae from veterinary medicine. J Antimicrob Chemother 70:1265-1267. http://dx.doi.org/10.1093/jac/dku485.
23. Pan YJ, Lin TL, Chen YH, Hsu CR, Hsieh PF, Wu MC, Wang JT. 2013. Capsular types of Klebsiella pneumoniae revisited by wzc sequencing. PLoS One 8:e80670. http://dx.doi.org/10.1371/journal.pone.0080670.
24. Pan YJ, Lin TL, Lin YT, Su PA, Chen CT, Hsieh PF, Hsu CR, Chen CC, Hsieh YC, Wang JT. 2015. Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications in capsule depolymerase treatment. Antimicrob Agents Chemother 59:1038-1047. http://dx.doi.org/10.1128/AAC.03560-14.
25. Wright MS, Perez F, Brinkac L, Jacobs MR, Kaye K, Cober E, van Duin D, Marshall SH, Hujer AM, Rudin SD, Hujer KM, Bonomo RA, Adams MD. 2014. Population structure of KPC-producing Klebsiella pneumoniae isolates from midwestern U.S. hospitals. Antimicrob Agents Chemother 58:4961-4965. http://dx.doi.org/10.1128/AAC.00125-14.
26. Pena I, Picazo JJ, Rodriguez-Avial C, Rodriguez-Avial I. 2014. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents 43:460-464. http://dx.doi.org/10.1016/j.ijantimicag.2014.01.021.
27. Jayol A, Poirel L, Brink A, Villegas MV, Yilmaz M, Nordmann P. 2014. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 58:4762-4766. http://dx.doi.org/10.1128/AAC.00084-14.
28. Beceiro A, Moreno A, Fernandez N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G. 2014. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother 58:518-526. http://dx.doi.org/10.1128/AAC.01597-13.
29. García-Quintanilla M, Pulido MR, Moreno-Martínez P, Martin-Peña R, López-Rojas R, Pachón J, McConnell MJ. 2014. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide. Antimicrob Agents Chemother 58:2972-2975. http://dx.doi.org/10.1128/AAC.02642-13.
30. Hsieh PF, Lin TL, Yang FL, Wu MC, Pan YJ, Wu SH, Wang JT. 2012. Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. PLoS One 7:e33155. http://dx.doi.org/10.1371/journal.pone.0033155.
31. Tsai CM, Frasch CE. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem 119:115-119. http://dx.doi.org/10.1016/0003-2697(82)90673-X.
32. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Turkoglu S, Nordmann P. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
33. Cannatelli A, Di Pilato V, Giani T, Arena F, Ambretti S, Gaibani P, D'Andrea MM, Rossolini GM. 2014. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob Agents Chemother 58:4399-4403. http://dx.doi.org/10.1128/AAC.02555-14.
34. Cheng HY, Chen YF, Peng HL. 2010. Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. J Biomed Sci 17:60. http://dx.doi.org/10.1186/1423-0127-17-60.
35. Link AJ, Phillips D, Church GM. 1997. Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization. J Bacteriol 179:6228-6237.
36. Lin TL, Yang FL, Yang AS, Peng HP, Li TL, Tsai MD, Wu SH, Wang JT. 2012. Amino acid substitutions of MagA in Klebsiella pneumoniae affect the biosynthesis of the capsular polysaccharide. PLoS One 7:e46783. http://dx.doi.org/10.1371/journal.pone.0046783.
37. 2+ sensing. J Bacteriol 184:5468-5478. http://dx.doi.org/10.1128/JB.184.19.5468-5478.2002.
38. Goldberg SD, Clinthorne GD, Goulian M, DeGrado WF. 2010. Transmembrane polar interactions are required for signaling in the Escherichia coli sensor kinase PhoQ. Proc Natl Acad Sci U S A 107:8141-8146. http://dx.doi.org/10.1073/pnas.1003166107.
39. Gunn JS, Hohmann EL, Miller SI. 1996. Transcriptional regulation of Salmonella virulence: a PhoQ periplasmic domain mutation results in increased net phosphotransfer to PhoP. J Bacteriol 178:6369-6373.
40. Lippa AM, Goulian M. 2009. Feedback inhibition in the PhoQ/PhoP signaling system by a membrane peptide. PLoS Genet 5:e1000788. http://dx.doi.org/10.1371/journal.pgen.1000788.
41. Wright MS, Suzuki Y, Jones MB, Marshall SH, Rudin SD, van Duin D, Kaye K, Jacobs MR, Bonomo RA, Adams MD. 2015. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance. Antimicrob Agents Chemother 59:536-543. http://dx.doi.org/10.1128/AAC.04037-14.